Delisting riskPopularity #4,595
MBAI · NASDAQ · Biotechnology

Check-Cap (MBAI)

Maintains legacy C-Scan assets while pursuing a merger with embodied-AI operator MBody.

$6.10
vs last close−0.28 (−4.39%)

Something off on this page? Send us feedback.

EPSReportedEstimate

Nov '23
Reported−$3.08
Estimate−$5.81
Surprise+47.0%

RevenueReportedEstimate

Nov '23
Reported
Estimate
Surprise

HistoryUpcoming

Date / PeriodEstimateReportedSurprise
May 2026
Feb 2026−$2.80
May 2024−$6.02
Nov 2023−$5.81−$3.08+47.0%
Date / PeriodEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
May 15, 2026
Feb 25, 2026−$2.80$623.0K
May 15, 2024−$6.02
Nov 27, 2023−$5.81−$3.08+47.0%